Agilent Technologies, Inc. (A)

128.68 -0.23 (-0.18%) At close: 04:00PM EST

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 18,000

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Michael R. McMullen	CEO, President & Director	3.66M	1.24M	1961
Mr. Robert W. McMahon	Senior VP & CFO	1.54M	N/A	1969
Mr. Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	1.31M	N/A	1965
Mr. Samraat S. Raha	Senior VP and President of Diagnostics & Genomics Group	1.14M	N/A	1973
Mr. Rodney Gonsalves	Principal Accounting Officer, VP & Corporate Controller	N/A	N/A	1966
Mr. John Kohl	Senior Vice President & Chief Information Officer	N/A	N/A	N/A
Mr. Michael Tang	Senior VP, General Counsel & Secretary	871.02k	290.31k	1974
Mr. Dominique P. Grau	Senior Vice President of Human Resources & Global Communications	936.31k	N/A	1959
Ms. Allison Ballmer	Senior Vice President of Strategy & Corporate Development	N/A	N/A	N/A
Ms. Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate Governance

Agilent Technologies, Inc.’s ISS Governance QualityScore as of December 1, 2023 is 8. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.